-
Mizuho Analyst On The Fence At Medicines Co. Pending Patent Appeal
Saturday, April 11, 2015 - 12:49pm | 272Read More...Uncertainty over patents on The Medicines Company (NASDAQ: MDCO)'s lead blood-clot drug Angiomax will hurt results going forward, an analyst said Friday. Hospira, Inc. (NYSE: HSP) is set to launch a generic version of Angiomax in June under a court ruling concerning a patent dispute last...
-
Market Wrap For February 10: Markets Cautious Ahead Of Yellen Testimony
Monday, February 10, 2014 - 5:47pm | 3302Read More...U.S. stocks traded mixed today as investors are anxiously waiting for Tuesday's testimony from Janet Yellen. Yellen will make her first appearance before the U.S. House of Representatives with a Senate session scheduled for Thursday. Elliot Spar, market strategist at Stifel told CNBC that "...
